Compare Huntington Bancshares Incorporated (HBAN) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Tenet Healthcare Corporation — how do they compare? Huntington Bancshares Incorporated trades at $15.41 (market cap $31.04B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Huntington Bancshares Incorporated is the larger of the two by market cap, and Huntington Bancshares Incorporated pays a 4.04% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Huntington Bancshares Incorporated for 52 Days and Tenet Healthcare Corporation for 15 Days on average.
| HBAN | THC | |
|---|---|---|
Market Cap | $31.04B | $20.98B |
Volume | 23,864,172 | 428,008 |
Sector | Financials | Health |
52-Week High | $19.27 | $280.77 |
52-Week Low | $15.02 | $161.37 |
Typical Hold Time | 52 Days | 15 Days |
Enterprise Value | $49.57B | $32.06B |
Dividend Yield | 4.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Huntington Bancshares (HBAN) trades at $15.17, down 1.04% on the day, reflecting recent pressure from margin headwinds and a lowered 2027 earnings outlook. The stock shows a bearish technical signal with moving averages indicating selling pressure, while fundamentals reveal a P/E of 11.67 and net income margin of 24.77%. Recent news highlights increased options activity and a new $0.16 dividend declaration, but investor sentiment is cautious amid interest rate challenges.
HBAN presents a mixed outlook with a consensus price target of $19.60 suggesting 29% upside, supported by shareholder returns via buybacks and dividends. However, risks include persistent net interest margin compression, competitive lending pressures, and macroeconomic sensitivity. The stock's valuation appears reasonable, but earnings misses and guidance cuts warrant close monitoring of upcoming Q3 2026 results for directional clarity.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
